Aspirin use is associated with decreased radiologically-determined thrombus sac volume in abdominal aortic aneurysms

Abstract

Introduction

Formation and renewal of intramural thrombus is associated with inflammation, and contributes to the complexity of aneurysm repair. Current cardiovascular pharmacotherapy includes several inflammatory modulators such as aspirin, statins, clopidogrel, and angiotensin-converting enzyme inhibitors. The purpose of our study was to investigate the effect of these inflammatory modulators on radiographically-determined thrombus sac volume.

Methods

Pre-operative computed tomography scans were reviewed in patients who underwent elective infrarenal aortic aneurysm repair. Thrombus sac volume was obtained using a Hounsfield unit restricted region growth algorithm. Co-morbid conditions such as diabetes mellitus and post-operative complications were evaluated compared to thrombus sac volume. Receiver–operator characteristic curves were generated for thrombus sac volume and patients on the various cardiovascular pharmacotherapies.

Results

A total of 266 patients (mean age = 72.6 ± 0.6 years; mean thrombus sac volume = 58.7 (34.4–89.0) cm³) were identified. Acetylsalicylic acid use was associated with a decreased thrombus sac volume ≤50 cm³ (AUC = 0.616, p = 0.013) whereas statins (p = 0.26), angiotensin-converting enzyme inhibitors (p = 0.46), and clopidogrel (p = 0.62) had no correlation to thrombus sac volume. Diabetes mellitus was not associated with thrombus sac volume (p = 0.31).

Conclusion

Acetylsalicylic acid use is associated with decreased thrombus sac volume in a patient population undergoing elective abdominal aortic aneurysms repair. The effect of acetylsalicylic acid over other anti-inflammatory and anti-platelet agents is possibly attributable to its distinct mechanism of cyclooxygenase-1 inhibition. Diabetes mellitus, a known correlate of aneurysm incidence, is not associated with thrombus burden. The potential to alter aneurysm thrombus volume, thereby affecting aneurysm morphology, may yield a more favorable aneurysmal repair.

Keywords

Inflammation thrombus-sac volume abdominal aortic aneurysm repair

Get full access to this article

View all access options for this article.

References

Parr

McCann

Bradshaw

et al . Thrombus volume is associated with cardiovascular events and aneurysm growth in patients who have abdominal aortic aneurysms. J Vasc Surg 2016; 53: 28–35.

Lindeman

JHN

Abdul-Hussien

Schaapherder

AFM

et al . Enhanced expression and activation of pro-inflammatory transcription factors distinguish aneurysmal from atherosclerotic aorta: IL-6- and IL-8-dominated inflammatory responses prevail in the human aneurysm. Clin Sci 2008; 114: 687–697.

Sagan

Mrowcecki

Mikolajczyk

et al . Local inflammation is associated with aortic thrombus formation in abdominal aortic aneurysm: relationship to clinical factors. Thromb Haemost 2012; 108: 812–823.

Speelman

Schurink

Bosboom

et al . The mechanical role of thrombus on the growth rate of abdominal aortic aneurysm. J Vasc Surg 2010; 51: 19–26.

Chaikof

Fillinger

Matsumura

et al . Identifying and grading factors that modify the outcome of endovascular aortic aneurysm repair. J Vasc Surg 2002; 35: 1061–1066.

Ahanchi

Carroll

Almaroof

et al . Anatomic severity grading score predicts technical difficulty, early outcomes, and hospital resource utilization of endovascular aortic aneurysm repair. J Vasc Surg 2011; 54: 1266–1272.

Rasheed

Cullen

Seaman

et al . Aortic anatomic severity grade correlates with resource utilization. J Vasc Surg 2016; 63: 569–576.

Aho

P-S

Niemi

Piilonen

et al . Interplay between coagulation and inflammation in open and endovascular abdominal aortic aneurysm repair-impact of intra-aneurysmal thrombus. Scand J Surg 2007; 96: 229–235.

Panek

Gacko

Palka

et al . Metalloproteinases, insulin-like growth factor-I and its binding proteins in aortic aneurysm. Int J Exp Pathol 2004; 85: 159–164.

10.

Carrell

Burnand

Booth

et al . Intraluminal thrombus enhances proteolysis in abdominal aortic aneurysms. Vascular 2006; 14: 9–16.

11.

Schror

Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis. Semin Thromb Hemost 1997; 23: 349–356.

12.

Touat

Ollivier

Dai

et al . Renewal of mural thrombus releases plasma markers and is involved in aortic abdominal aneurysm evolution. Am J Pathol 2006; 168: 1022–1030.

13.

Bailey

Aggarwal

Bridge

et al . Aspirin therapy is associated with less compact fibrin networks and enhanced fibrinolysis in patients with abdominal aortic aneurysm. J Thromb Haemost 2015; 13: 795–801.

14.

Lindholt

Bjorck

Michel

JB.

Anti-platelet treatment of middle-sized abdominal aortic aneurysms. Curr Vasc Pharmacol 2013; 11: 305–313.

15.

Yeung

Hernandez-Boussard

Song

et al . Preoperative thrombus volume predicts sac regression after endovascular aneurysm repair. J Endovasc Ther 2009; 16: 380–388.

16.

Wild

Dattani

Stather

et al . Effect of anticoagulation and antiplatelet therapy on incidence of endoleaks and sac size expansions after endovascular aneurysm repair. Ann Vasc Surg 2014; 28: 554–559.

17.

Sadek

Dexter

Rockman

et al . Preoperative relative abdominal aortic aneurysm thrombus burden predicts endoleak and sac enlargement after endovascular anerysm repair. Ann Vasc Surg 2013; 27: 1036–1041.

18.

Fujita

Resch

Kristmundsson

et al . Impact of intrasac thrombus and a patent inferior mesenteric artery on EVAR outcome. J Endovasc Ther 2010; 17: 534–539.

19.

Sampaio

Panneton

Mozes

et al . Aneurysm sac thrombus load predicts type II endoleaks after endovascular aneurysm repair. Ann Vasc Surg 2005; 19: 302–309.

20.

Dai

Louedec

Philippe

et al . Effect of blocking platelet activation with AZD6140 on development of abdominal aortic aneurysm in a rat aneurysmal model. J Vasc Surg 2009; 49: 719–727.

21.

Rouer

Meilhac

Delbosc

et al . A new murine model of endovascular aortic aneurysm repair. J Vis Exp 2013; e50740.